2025 Speakers

Daniela Kleine-Kohlbrecher

Project Director, Immuno-Oncology

Evaxion Biotech

Heather Shaw

Consultant Medical Oncologist

Swarm Oncology

Jian Yan

Vice President, Research & Discovery

Geneos Therapeutics

Jingwei Sun

Vice President of R&D

Grit Biotechnology

John Campbell

Chief Scientific Officer

Swarm Oncology

Jon Moore

Chief Scientific Officer

Epitopea

Katka Franke

Senior Director Cancer Antigen Discovery & Validation

CureVac

Luigi Aurisicchio

Chief Executive Officer

Neomatrix

Marie-Laure Santiago Raber

Chief Scientific Officer

Amal Therapeutics

Massimo Fantini

Director, Research & Development

Precision Biologics

Maurizio Ceppi

Chief Scientific Officer

Transgene

Morena D’Alise

Senior Vice President, Immunology

Nouscom

Nermeen Varawalla

Chief Medical Officer

Scancell

Ola Nilsson

Head Of Neoantigen Production, Development & Clinical Processing

NEOGAP Therapeutics

Olivier Lantz

Head of the Hospital Clinical Immunology Laboratory, Group Leader

Institut Curie

Peter Johannes Holst

Chief Scientific Officer

HERVolutions Therapeutics

Prasun Chakraborty

Chief Scientific Officer

Genevation

Reagan Jarvis

Chief Executive Officer

Anocca

Robbert Spaapen

Associate Director

AstraZeneca

Sarah Maguire

Chief Scientific Officer

AilseBio

Sebastian Klobuch

Medical Oncologist

The Netherlands Cancer Institute

Ulrike Gnad-Vogt

Senior Vice President, Clinical Development

CureVac

Vanesa Bol

Director, Vaccines Discovery Data Sciences

GSK

Yaohe Wang

Chief Executive Officer

VacV Biotherapeutics

REGISTER
BRAND NEW AGENDA
PARTNER